2024

1. Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab

   International Journal of Dermatology

2. Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis

   Clinical and Experimental Dermatology